Medpace director sells 3,858 shares at avg $617.81

For Medpace Holdings, Inc. (MEDP), director Robert O. Kraft reported an option exercise and same-day sale.

Rhea-AI Filing Summary

For Medpace Holdings, Inc. (MEDP), director Robert O. Kraft reported an option exercise and same-day sale. On 2026-08-26, he exercised stock options for 3,858 shares of common stock at an exercise price of $84.36 per share, fully using an option that vested on May 13, 2021 and leaving 0 options from that grant outstanding. He then sold 3,858 common shares on the same date at a weighted average price of $617.81 per share, in multiple trades ranging from $617.73 to $618.43, and stands ready to provide detailed pricing information upon request.

Insider Trade Summary

Exercise and Sale: 3,858 shares ($2.06M approx. pre-tax spread)

Exercise and Sale 3 txns

Insider Kraft Robert O.

Role Director

Sold 3,858 shs ($2.38M)

Approx. gross sale proceeds $2.38M

Approx. exercise cost $325K

Approx. pre-tax spread $2.06M

Type	Security	Shares	Price	Value
Exercise	Stock Option (Right to Buy) F2	3,858	$0.00	$0.00
Exercise	Common Stock	3,858	$84.36	$325K
Sale	Common Stock F1	3,858	$617.81	$2.38M

Holdings After Transaction: Stock Option (Right to Buy) — 0 contracts (Direct); Common Stock — 955 shares (Direct)

Footnotes (2)

1. F1. The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $617.73 to $618.43. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.
2. F2. The option vested in full on May 13, 2021.

Key Figures

Options exercised: 3,858 shares Exercise price: $84.36 per share Shares sold: 3,858 shares +5 more

8 metrics

Options exercised 3,858 shares Stock option (right to buy) exercised on 2026-08-26

Exercise price $84.36 per share Conversion or exercise price of stock option exercised for 3,858 shares

Shares sold 3,858 shares Common stock sale on 2026-08-26 following option exercise

Weighted average sale price $617.81 per share Weighted average for sales ranging from $617.73 to $618.43 per share

Sale price range $617.73–$618.43 per share Price range for multiple sale transactions totaling 3,858 shares

Options remaining from this grant 0 shares Total shares following derivative transaction for this stock option grant

Option vesting date May 13, 2021 Footnote states the option vested in full on this date

Option expiration date 2027-05-15 Expiration date of the exercised stock option

Key Terms

Stock Option (Right to Buy), weighted average price, derivative security

3 terms

Stock Option (Right to Buy) financial

"security_title: Stock Option (Right to Buy)"

weighted average price financial

"The reported price is a weighted average price."

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

derivative security financial

"Exercise or conversion of derivative security"

A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did MEDP director Robert O. Kraft report on August 26, 2026?

On 2026-08-26, Robert O. Kraft exercised stock options for 3,858 MEDP shares at $84.36 per share and then sold 3,858 common shares in the market at a weighted average price of $617.81 per share, in trades ranging from $617.73 to $618.43.

How many Medpace (MEDP) shares did Robert O. Kraft sell and at what price?

Robert O. Kraft sold 3,858 MEDP common shares on 2026-08-26 at a weighted average price of $617.81 per share, with individual trades executed in a price range from $617.73 to $618.43 per share.

What stock option did Robert O. Kraft exercise in the latest MEDP Form 4?

He exercised a stock option for 3,858 MEDP shares of common stock at an exercise price of $84.36 per share. The filing states that this option vested in full on May 13, 2021 and that 0 options from this grant remain after the exercise.

Did Robert O. Kraft retain any shares from the August 26, 2026 MEDP option exercise?

Based on the reported transactions, he acquired 3,858 shares through the option exercise and sold 3,858 shares the same day. The filing does not report any remaining shares from this specific exercise-leg combination.

What does the weighted average price disclosure mean in the MEDP Form 4 filing?

The filing states that the reported sale price is a weighted average price. The 3,858 shares were sold in multiple transactions with prices between $617.73 and $618.43 per share, and the reporting person undertakes to provide complete trade-by-trade pricing upon request.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/28/2026 - 04:33 PM EDT Accepted by SEC EDGAR 08/28/2026 - 04:32 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kraft Robert O.

(Last) (First) (Middle)

C/O MEDPACE HOLDINGS, INC.

5375 MEDPACE WAY

(Street)

CINCINNATI OHIO 45227

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Medpace Holdings, Inc. [ MEDP ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/26/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/26/2026		M		3,858	A	$84.36	4,813	D
Common Stock	08/26/2026		S		3,858	D	$617.81(1)	955	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$84.36	08/26/2026		M			3,858	(2)	05/15/2027	Common Stock	3,858	$0	0	D

Explanation of Responses:

1. The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $617.73 to $618.43. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.

2. The option vested in full on May 13, 2021.

Remarks:

	/s/ Stephen P. Ewald, Attorney-in-Fact for Robert O. Kraft	08/28/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)